High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients

Baldessarini, 1988, Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosis, Arch Gen Psychiatry, 45, 79, 10.1001/archpsyc.1988.01800250095013 Burns, 1984, 3-N-[11-C]methylspiperone, a ligand binding to dopmaine receptors: Radiochemical synthesis and biodistribution in mice, J Nucl Med, 25, 1222 Cooper, 1983, Submicrogram quantification of chlorpromazine in plasma by high-performance liquid chromatography with electrochemical detection, J Pharmacol Sci, 72, 1259, 10.1002/jps.2600721106 Coppens, 1988, PET-scanning with C11-labeled methylspiperon and prolactin provocation tests in therapy-resistant psychotic patients (Abstract), Psychopharmacology, 83 Crow, 1980, Molecular pathology of schizophrenia: More than one disease process?, Br med J, 280, 66, 10.1136/bmj.280.6207.66 Crow, 1985, The two syndrome concept: Origins and current status, Schizophr Bull, 11, 471, 10.1093/schbul/11.3.471 Dahl, 1986, Plasma level monitoring of antipsychotic drugs: Clinical utility, Clin Pharmacokinet, 11, 36, 10.2165/00003088-198611010-00003 Davis, 1986, The natural course of schizophrenia and effective maintenance drug treatment, J Clin Psychopharmacol, 6, 25, 10.1097/00004714-198602001-00002 Dhar, 1984, Improved liquid chromatography determination of haloperidol in plasma, Clin Chem, 30, 1228, 10.1093/clinchem/30.7.1228 Farde, 1988, Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs, Arch Gen Psychiatry, 45, 71, 10.1001/archpsyc.1988.01800250087012 Farde, 1988, An open label trial of raclopride in acute schizophrenia: Conformation of D2-dopamine receptor occupancy by PET, Psychopharmacology, 94, 1, 10.1007/BF00735871 Götze, 1987, Zur Problematik Schizophrener: Schizophrenicähnlicher Psychosen nach Schördel-Hirn-Trannen, Nervenarzt, 49, 361 Keefe, 1987, Characteristics of very poor outcome schizophrenia, Am J Psychiatry, 144, 889, 10.1176/ajp.144.7.889 Mazière, 1985, In vivo quantitative imaging of dopamine receptors in human brain using positron tomograph and [76Br]-bromospiperone, Eur J Pharmacol, 114, 267, 10.1016/0014-2999(85)90369-3 Paans, 1985, A rotating double-headed positron camera, J Nucl Med, 26, 1466 Rutgers, 1987, Tracing of dopamine receptors in hemiparkinsonism with positron emission tomography, J Neurol Sci, 80, 237, 10.1016/0022-510X(87)90158-4 Seeman, 1984, Bimodal distribution of dopamine receptor densities in brains of schizophrenics, Science, 225, 728, 10.1126/science.6147018 Wing, 1974 Wolkin, 1989, Dopamine blockade and clinical response: Evidence for two biological subgroups of schizophrenia, Am J Psychiatry, 46, 905 Wong, 1986, Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics, Science, 234, 1558, 10.1126/science.2878495